Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.

Abstract

Multidrug resistance (MDR) is a major impediment to cancer treatment. Here, for the first time, we investigated the chemo-sensitizing effect of Noscapine (Nos) at low concentrations in conjunction with docetaxel (DTX) to overcome drug resistance of triple negative breast cancer (TNBC). In vitro experiments showed that Nos significantly inhibited proliferation of TNBC wild type (p < 0.01) and drug resistant (p < 0.05) TNBC cells. Nos followed by DTX treatment notably increased the cell viability (~1.3 fold) markedly (p < 0.05) in 3D models compared to conventional 2D systems. In vivo oral administration of Nos (100 mg/kg) followed by intravenous DTX (5 mg/kg) liposome treatment revealed regression of xenograft tumors in both wild type (p < 0.001) and drug-resistant (p < 0.05) xenografts. In wild type xenografts, combination of Nos plus DTX group showed 5.49 and 3.25 fold reduction in tumor volume compared to Nos and DTX alone groups, respectively. In drug-resistant xenografts, tumor volume was decreased 2.33 and 1.41 fold in xenografts treated with Nos plus DTX significantly (p < 0.05) compared to Nos and DTX alone respectively and downregulated the expression of anti-apoptotic factors and multidrug resistance proteins. Collectively, chemo-sensitizing effect of Nos followed by DTX regime provide a promising chemotherapeutic strategy and its significant role for the treatment of drug-resistant TNBC.

• Authors: Ravi Doddapaneni, Ketan Patel, Nusrat Chowdhury, Mandip Singh
• Journal: Scientific reports (Sci Rep) Vol. 7 Issue 1 Pg. 15824 (Nov 20 2017) ISSN: 2045-2322 [Electronic] England
• PMID: 29158480 (Publication Type: Journal Article)

Chemical References

• Liposomes
• Taxoids
• Docetaxel
• Noscapine

Topics

• Animals
• Antineoplastic Combined Chemotherapy Protocols (administration & dosage, chemistry)
• Apoptosis (drug effects)
• Cell Line, Tumor
• Cell Survival (drug effects)
• Docetaxel (administration & dosage, adverse effects)
• Drug Resistance, Neoplasm (drug effects)
• Female
• Humans
• Liposomes (administration & dosage, chemistry)
• Mice
• Noscapine (administration & dosage)
• Taxoids (administration & dosage)
• Triple Negative Breast Neoplasms (drug therapy, genetics, pathology)
• Xenograft Model Antitumor Assays